Angelo Antonini

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Günter U. Höglinger, Gesine Respondek, María Stamelou et al. · Movement Disorders · 2017 · 2.2K citations · Full text

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

Paolo Barone, Angelo Antonini, Carlo Colosimo et al. · Movement Disorders · 2009 · 1.4K citations

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease

R Zanettini, Angelo Antonini, Gemma Gatto et al. · New England Journal of Medicine · 2007 · 874 citations · Full text

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 683 citations

Advanced Parkinson, Continuous Intrajejunal Infusion, Neurology +3

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

Franz X. Vollenweider, Klaus L. Leenders, C Scharfetter et al. · European Neuropsychopharmacology · 1997 · 354 citations

Positron Emission Tomography, Psychoactive Drug, Psychiatry +14